0
0
0
0
1
2
3
$0
Is Medtronic solid or fragile? The Finex Financial Health Scanner reads MDT's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $36.4B |
|---|---|
| Net income | $4.8B |
| Operating margin | 17.8% |
| Net margin | 13.2% |
| Cash and investments | $9.2B |
| Total debt | $28.0B |
| Free cash flow | $5.4B |
| Revenue growth (1 year) | 8.4% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.